Hematologic abnormalities associated with various types of retinal vein occlusion

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 3, 2002, Pages 180-196

  Hayreh, Sohan ^a   Zimmerman, Bridget M ^b   Podhajsky, Patricia ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 GLOBULIN; ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; ANTITHROMBIN III; ANTITHROMBOCYTIC AGENT; GLUCOSE; HEMOGLOBIN; HEPARIN; UREA; URIC ACID; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GROUPS BY AGE; HEMATOCRIT; HEMATOLOGIC DISEASE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMATOLOGIC DISEASES; HEMATOLOGIC TESTS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION;

EID: 0036946829     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-001-0421-3     Document Type: Article

References (71)

1. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 341:134-138
2. Andrews A, Hickling P (1997) Thrombosis associated with antiphospholipid antibody in juvenile chronic arthritis. Lupus 6:556-557
3. Arend O, Remky A, Jung F, Kiesewetter H, Reim M, Wolf S (1996) Role of rheologic factors in patients with acute central retinal vein occlusion. Ophthalmology 103:80-86
4. Biousse V, Newman NJ, Sternberg P (1997) Retinal vein occlusion and transient monocular visual loss associated with hyperhomocysteinemia. Am J Ophthalmol 124:257-260
5. Boyd S, Owens D, Gin T, Bunce T, Sherafat H, Perry D, Hykin PG (2001) Plasma homocysteine, methylene tetrahydrofolate reductase C677 T and factor II G20210 A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol 85:1313-1315
6. Cattaneo M (1999) Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 81:165-176
7. Ciardella AP, Yannuzzi LA, Freund KB, DiMichele D, Nejat M, De Rosa JT, Daly JR, Sisco L (1998) Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina 18:308-315
8. Cobo-Soriano R, Sánchez-Ramón S, Aparicio MJ, Teijeiro A, Vidal P, Suárez-Leoz M, Rodriguez-Mahou M, Rodriguez-Huerta A, Fernández-Cruz E, Cortés C (1999) Antiphospholipid antibodies and retinal thrombosis in patients with risk factors: a prospective case-control study. Am J Ophthalmol 128:725-732
9. Coniglio M, Platania A, Di Nucci GD, Arcieri P, Modzrewska R, Mariani G (1996) Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusion. Thromb Res 83:183-188
10. Dahlbäck B (1994) Physiological anticoagulation: resistance to activated protein C and venous thromboembolism. J Clin Invest 94:923-927
11. Dhôte R, Bachmeyer C, Horellou MH, Toulon P, Christoforov B (1995) Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol 120:388-389
12. Dodson PM, Gallon DJ, Winder AF (1981) Retinal vascular abnormalities in the hyperlipidemias. Trans Ophthalmol Soc UK 101:17-21
13. Dudman NP (1999) An alternative view of homocysteine. Lancet 354:2072-2074
14. Ellis CJ, Hamer DB, Hunt RW, Lever AF, Lever RS, Pearl WS, Walker SM (1964) Medical investigation of retinal vascular occlusion. Br Med J 2:1093-1098
15. Engesser L, Broekmans AW, Briët E, Brommer EJP, Bertina RM (1987) Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 106:677-682
16. Faude S, Faude F, Siegemund A, Wiedemann P (1999) APC-Resistenz bei Patienten mit Zentralvenenverschluss. Vergleich mit Patienten mit tiefer Becken- un Veinvenenthrombose und gesunder Kontrollgruppe. Ophthalmologe 96:594-599
17. Feman SS, Stein RS (1981) Waldenstrom's macroglobulinemia, a hyperviscosity manifestation of venous stasis retinopathy. Int Ophthalmol 4:107-112
18. Glacet-Bernard A, Bayani N, Chretien P, Cochard C, Lelong F, Coscas G (1994) Antiphospholipid antibodies in retinal vascular occlusions. Arch Ophthalmol 112:790-795
19. Glacet-Bernard A, Chabanel A, Lelong F, Samama MM, Coscas G (1994) Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors. Ophthalmology 101:1483-1487
20. Glueck CJ, Bell H, Vadlamani L, Gupta A, Fontaine RN, Wang P, Stroop D, Gruppo R (1999) Heritable thrombophilia and hypofibrinolysis: possible causes of retinal vein occlusion. Arch Ophthalmol 117:43-49
21. Gottlieb JL, Blice JP, Mestichelli B, Konkle BA, Benson WE (1998) Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol 116:577-579
22. Greiner K, Hafner G, Dick B, Peetz D, Prellwitz W, Pfeiffer N (1999) Retinal vascular occlusion and deficiencies in protein C pathway. Am J Ophthalmol 128:69-74
23. Hayreh SS (1965) Occlusion of the central retinal vessels. Br J Ophthalmol 49:626-645
24. Hayreh SS (1976) So-called 'central retinal vein occlusion'. I. Pathogenesis, terminology, clinical features. Ophthalmologica 172:1-13
25. Hayreh SS (1980) Central retinal vein occlusion. In: Mausolf FA (ed). The eye and systemic disease, 2nd edn. C.V. Mosby, St. Louis, pp 223-275
26. Hayreh SS (1983) Classification of central retinal vein occlusion. Ophthalmology 90:458-474
27. Hayreh SS (1998) Central retinal vein occlusion. Ophthalmol Clin North Am 11:559-590
28. Hayreh SS, Hayreh MS (1980) Hemicentral retinal vein occlusion. Pathogenesis, clinical features, and natural history. Arch Ophthalmol 98:1600-1609
29. Hayreh SS, van Heuven WAJ, Hayreh MS (1978) Experimental retinal vascular occlusion. I. Pathogenesis of central retinal vein occlusion. Arch Ophthalmol 96:311-323
30. Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF (1983) Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 90:488-506
31. Hayreh SS, Klugman MR, Beri M, Kimura AE, Podhajsky P (1990) Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol 228:201-217
32. Hayreh SS, Joos KM, Podhajsky PA, Long CR (1994) Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118:766-780
33. Hayreh SS, Zimmerman MB, Podhajsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117:429-441
34. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P (2001) Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131:61-77
35. den Heijer M, Koster T, Blom HJ, Bos GM, Briët E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759-762
36. Hodgkins PR, Perry DJ, Sawcer SJ, Keast-Butler J (1995) Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion. Eye 9:760-762
37. Iannaccone A, Letizia C, Pazzaglia S, Vingolo EM, Clemente G, Pannarale MR (1998) Plasma endothelin-1 concentrations in patients with retinal vein occlusion. Br J Ophthalmol 82:498-503
38. Iijima H, Gohdo T, Imai M, Tsukahara S (1998) Thrombin-antithrombin III complex in acute retinal vein occlusion. Am J Ophthalmol 126:677-682
39. Ingerslev J (1999) Thrombophilia: a feature of importance in retinal vein thrombosis? Acta Ophthalmol Scand 77:619-621
40. Kalayci D, Gurgey A, Guven D, Parlak H, Hasirpi H (1999) Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion. Acta Ophthalmol Scand 77:622-624
41. Kleiner RC, Najarian LV, Schatten S, Jabs DA, Patz A, Kaplan HJ (1989) Vaso-occlusive retinopathy associated with anti-phospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 96:896-904
42. Kohner EM, Cappin JM (1974) Do medical conditions have an influence on central retinal vein occlusion? Proc Roy Soc Med 67:20-22
43. Larsson J, Olafsdottir E, Bauer B (1996) Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 80:200-202
44. Larsson J, Sellman A, Bauer B (1997) Activated protein C resistance in patients with central retinal vein occlusion. Br J Ophthalmol 81:832-834
45. Larsson J, Hillarp A, Olafsdottir E, Bauer B. (1999) Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand 77:634-637
46. Linna T, Ylikorkala A, Kontula K, Puska P, Tervo T (1997) Prevalence of factor V Leiden in young adults with retinal vein occlusion. Thromb Haemost 77:214-216
47. Ma AD, Abrams CS (1998) Activated protein C resistance, Factor V Leiden, and retinal vessel occlusion. Retina 18:297-300
48. Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, Prisco D. (2001) Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 86:772-776
49. Mazza C, Palmieri L, Mazzilli G (1968) L'aggregazione piastrinica nelle trombosi venose della retina. Ann Ottal 94:133-139
50. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R, et al. (1985) The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37:1-31
51. National Center for Health Statistics (1994) Health, United States, 1994. Public Health Service, Hyattsville, MD, p 164
52. Remky A, Arend O, Jung F, Kiesewetter H, Reim M, Wolf S (1996) Haemorheology in patients with branch retinal vein occlusion with and without risk factors. Graefes Arch Clin Exp Ophthalmol 234:S8-S12
53. Salomon O, Moissciev J, Rosenberg N, Vidne O, Yassur I, Treister G, Steinberg DM, Seligsohn U (1998) Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis 9:617-622
54. Samama MM, Simon D, Horellou MH, Trossaert M, Elalamy I, Conard J (1996) Diagnosis and clinical characteristics of inherited activated protein C resistance. Hemostasis 26[Suppl 4]:315-330
55. Scott JA, Arnold JJ, Currie JM, Broadfoot C, Davidson M, Kelly KF, Graham A, Kirkpatrick JNP, Greaves M (2001) No excess of factor V:Q506 genotype but high prevalence of anticardiolipin antibodies without antiendothelial cell antibodies in retinal vein occlusion in young patients. Ophthalmologica 215:217-221
56. Snyers B, Lambert M, Hardy J-P (1990) Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina 10:255-260
57. Speicher L, Philipp W, Kunz FJ (1992) Factor XII deficiency and central retinal vein occlusion. Lancet 340:237
58. Svensson PJ, Dahlbäck B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-522
59. Tekeli O, Gursel E, Buyurgan H (1999) Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol Scand 77:628-630
60. The Eye Disease Case-Control Study Group (1993) Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116:286-296
61. The Eye Disease Case-Control Study Group (1996) Risk factors for central retinal vein occlusion. Arch Ophthalmol 114:545-554
62. The Eye Disease Case-Control Study Group (1998) Risk factors for hemicentral retinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion. Ophthalmology 105:765-771
63. Vine AK (2000) Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 129:112-114
64. Vine AK (2000) Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 129:640-644
65. Vine AK, Samama MM (1997) Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in patients with central retinal vein occlusion. Am J Ophthalmol 124:673-676
66. von Michel J (1878) Die spontane Thrombose der vena centralis des Opticus. Graefes Arch Clin Exp Ophthalmol 24(2):37-70
67. Walsh PN, Goldberg RE, Tax RL, Magargal LE (1977) Platelet coagulant activities and retinal vein thrombosis. Thromb Haemost 38:399-406
68. Wenzler EM, Rademakers AJ, Boers GH, Cruysberg JR, Webers CA, Deutman AF (1993) Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 115:162-167
69. Wiechens B, Schroder JO, Potzsch B, Rochels R (1997) Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol 123:848-850
70. Williamson TH, Rumley A, Lowe GDO (1996) Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 80:203-208
71. Zirm M, Schmut O (1974) Zur immunologischen Diagnostik bei Zentralvenenthrombosen. Klin Monatsbl Augenheilkd 164:478-485